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Tumour-necrosis-factor-induced acute pulmonary 
injury 
A) Exogenous TNF 
Several investigators have injected purified, 
recombinant TNF into experimental animals and ob- 
served pulmonary injury. One of the first reports was 
by Tracey et al. (1986) who injected recombinant hu- 
man TNF (rhTNF) into rats. High doses (I .8 mg/kg 
body weight) were used, and the rats developed a con- 
stellation of signs and pathologic findings which were 
similar to those observed in septic shock. Multiple 
organs were affected, including the lungs which 
showed inflammation and haemorrhage. This group 
also demonstrated that 0.1 mg/kg of rhTNF ad- 
ministered by intra-arterial infusion would induce 
multiple haemorrhagic pulmonary lesions (Tracey et 
al., 1987). In another study, acute lung injury was 
also observed 3.5 h after injection of rhTNF into rats 
(Chang et al., 1989). These investigators were not 
able to inhibit the lung injury with a platelet- 
activating factor antagonist, in contrast to findings 
with the small intestine as described below. A state 
similar to adult respiratory distress syndrome was in- 
duced in rats by giving 4x IO5 units of TNF per kg 
per h for 24 h (Ferrari-Baliviera et al., 1989). The rats 
developed significant alterations in the static com- 
pliance of the lungs, as well as an increase in the 
weight of the lungs. Histologic examination disclosed 
focal, intermittent inflammation. Gaskill has also 
reported that continuous infusion of rhTNF at 
100 pg/kg/day causes a significant increase in the wet 
weight of the lungs (Gaskill, 1988). Mice have been 
used as experimental animals and 500,000 units/kg 
of rhTNF will induce microthrombi in the lungs, but 
very little actual tissue damage (Talmadge et al., 
1987). We also were not able to document significant 
lung injury in mice after intravenous injection of 
IO pg of rhTNF into mice (Remick et al., 1987), 
although there were substantial lesions in the intes- 
tines (described below). At the dose of 100 pg, there 
was evidence of pulmonary injury (Remick and 
Kunkel, in press). 
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Other animals have been injected with rhTNF and 
the pathology documented; in particular, guinea pigs 
have also been used as experimental animal models 
for TNF-induced acute lung injury. Injection of 
rhTNF at 1 x lo6 units/kg caused lung injury, as 
measured by increases in albumin leakage and lung 
water (Stephens ef al., 1988a). There were also more 
neutrophils per alveolus after TNF treatment. Treat- 
ment with pentoxifylline (Lilly ef al., 1989) or deple- 
tion of neutrophils (Stephens ef al., 1988b) would 
prevent the lung injury induced by TNF. It should 
be noted that prevention of lung injury in the face 
of decreased numbers of neutrophils is controversial. 
Neutropenic patients may still develop adult respira- 
tory distress syndrome (Maunder et al., 1986; Ogni- 
bene et al., 1986). Additionally, TNF-induced lung 
injury in sheep (12 yg/kg) is not attenuated by prior 
depletion of neutrophils (Horvath et al., 1988). The 
differences in these studies may relate to the differ- 
ent species of animals that were used (guinea pig vs. 
sheep), the dose of TNF that was administered, or 
the method used to neutrophil-deplete the animals. 
Two other species that have been used to inves- 
tigate the toxicity of TNF are dogs and rabbits, and 
in both species TNF will cause lung injury. In dogs, 
60 pg/kg of rhTNF were shown to cause early de- 
rangements of oxygenation, as measured by sophisti- 
cated physiologic parameters (Eichacker ef al., 1991). 
In rabbits, 1 Kg/kg will cause “hepatization” of the 
lung, with neutrophils and red blood cells in the al- 
veolus (Okusawa ef al., 1988). 
The previous work has given recombinant TNF 
systemically, and at much higher doses than would 
be observed after the induction of septic shock. In 
many cases, local production of cytokines may be 
critical, and the toxicity of aerosolized TNF has been 
specifically examined. Debs et al. (1988) instilled 
2 mg/rat of rhTNF into the lungs, and margination 
of neutrophils was observed 1 day later, followed by 
pulmonary haemorrhage. Ulich ef al. (1991) instilled 
less TNF (5,000 units/rat) and observed a marked 
influx of neutrophils into the lung which peaked 24 h 
after exposure. Taken together, these studies indicate 
that TNF will induce lung injury, whether it is given 
locally or injected intravenously. 
We have also closely examined the pulmonary 
pathology observed after injection of TNF. For our 
studies, we prepared recombinant murine TNF. The 
isolated protein migrated as a single band on SDS- 
polyacrylamide gel electrophoresis, reacted with an 
antibody directed against murine TNF (Chensue et 
al., 1988) and induced cytotoxicity of TNF-sensitive 
target cells. Endotoxin was less than 0.3 pg/pg of 
recombinant material. The rmTNF was diluted in 
normal saline with 0.05 ‘70 bovine serum albumin as 
a carrier and was then injected intravenously. Two 
sets of controls were done: i) TNF was heat- 
inactivated by boiling for 2 h and ii) vehicle alone 
which contained the equivalent amount of endotox- 
in found in the recombinant protein. Mice were 
evaluated 4 h after intravenous injection. The degree 
of neutrophilic infiltrate was quantitated biochemi- 
cally by measuring the myeloperoxidase content of 
the lung (Remick et al., 1990). The rmTNF induced 
a profound neutrophil sequestration within the lung 
(fig. 1). This was not due to contaminating endo- 
toxin, since heat inactivation, or injection of vehicle 
with the same amount of endotoxin, did not induce 
similar changes. It has previously been reported that 
endotoxin will synergize with TNF to induce toxici- 
ty (Ozaki, Oyama, and Kume, 1989; Rothstein and 
Schreiber, 1988); however, nanogram quantities of 
endotoxin were needed and our preparation con- 
tained only 3 picograms. 
B) Endogenous TNF 
The previous section dealt exclusively with the 
documentation of lung injury observed after ex- 
posure to injected TNF and these studies provide im- 
portant, specific information about the toxic effects 
of TNF. However, all of the studies are inherently 
flawed, since they do not completely replicate the 











Fig. 1. Effects of rmTNF on lungs. 
Ten yg of rmTNF were injected intravenously and the 
lungs harvested 4 h later and processed for myeloperoxi- 
dase activity (MPO). The TNF induced substantial recruit- 
ment of neutrophils to the lung. Vehicle indicates the 
vehicle alone which contained the same amount of con- 
taminating endotoxin as the rmTNF preparation 
(3 picograms). Heated TNF was heat-inactivated prior to 
injection. The rmTNF induced significantly more pulmo- 
nary MPO than either of these 2 controls. (p < 05 by 
Student-Newman-Keuls). 
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tory response. This is particularly important for 
cytokines, where early alarm cytokines such as TNF 
and IL1 will induce the synthesis of later cytokines 
(DeForge et al., 1992). Cytokines will also synergize 
with each other to induce organ injury, as has been 
documented for the interactions between TNF and 
IL1 (Okusawa ef al., 1988; Waage and Espevik, 
1988). To complete the story of TNF-induced lung 
injury, it is necessary to look at experimental animals 
with lung injury and determine if TNF is present. If 
TNF can be found, then blocking with an antibody 
should provide protection against the injury. Table I 
lists several experimental models of acute lung inju- 
ry where TNF has been implicated as a causative 
agent. This is not meant to be an exhaustive listing, 
but is provided mostly to show the wide range of dis- 
ease processes that are believed to mediated by TNF. 
No current discussion of the toxicity of TNF 
would be complete without mentioning the protec- 
tive role of TNF. Upregulation of TNF gene expres- 
sion is a normal physiologic response to infections, 
and blunting TNF may actually allow enhanced 
growth of organisms. This was directly shown in pul- 
monary infections induced by Legionella pneunlophi- 
la, where treatment with TNF would augment the 
ability of mice to clear a pulmonary infection (Blan- 
chard et al., 1988). Further work by Nelson et al. 
(1991) has shown that acute ethanol ingestion 
decreases the production of TNF in lung lavage fluid 
and increases the number of bacteria (Klebsiella 
pneumoniae) in the lung. Multiple other studies have 
shown that addition of anti-TNF antibodies will 
reduce the hosts’ ability to clear an infectious 
challenge (Eskandari el al., 1992; Echtenacher et al., 
1990; Havell, 1989). As with many aspects of inflam- 
mation, the proper balance must be maintained be- 
tween the pro-inflammatory, beneficial effects of 
TNF and the organ-damaging potential of the 
cytokine. 
TNF-induced chronic pulmonary damage 
TNF has also been implicated as a mediator of 
chronic pulmonary injury. The bleomycin model of 
pulmonary fibrosis has been used successfully to 
study the pathogenesis and progression of pulmonary 
fibrosis. Investigators have shown that bleomycin will 
directly stimulate production of TNF (Scheule ef al., 
1992; Micallef et al., 1991 ; Everson and Chandler, 
1992). The role of TNF has been most extensively 
studied by Piguet and associates (1989). They instilled 
bleomycin intratracheally and found evidence for 
mRNA coding for TNF 5 to 15 days later. They were 
a!so able to inhibit the progression of pulmonary 
fibrosis by treatment with an anti-TNF antibody. 
Pulmonary fibrosis may also be initiated by sili- 
ca particles, and alveolar cells will respond to silica 
by producing TNF (Bissonnette and Rola- 
Pleszczynski, 1989). Piguet and associates have also 
investigated this model and demonstrated that addi- 
tion of exogenous TNF will accelerate silica-induced 
pulmonary fibrosis (Piguet ef al., 1990). Further 
proof of the importance of TNF was provided by an- 
tibody blocking experiments. 
TNF-induced intestinal damage 
There is less published data on the effects of TNF 
on the intestinal tract. Tracey’s original work 
documented damage to the intestinal tract, although 
several organs were also affected (Tracey et al., 1986). 
Other investigators have also found intestinal injury 
after injection of recombinant human TNF which 
consisted of diarrhoea (Gaskill, 1988), apoptotic cells 
in the mucosa of the duodenum (Talmadge et al., 
1987) or haemorrhagic necrosis of the caecum (Chang 
et al., 1989). Interestingly, Ozaki, Oyama, and Kume 
found pathologic changes in rats restricted to the in- 
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Remick et al., 1990 
Warren et al., 1989 
Colletti ef al., 1990 
Caty ef al., 1990 
Goldman ef al., 1990 
For each of the models, TNF was detected either in the circula[ion or in the lavage fluid. All of these are models of acute lung injury, 
which develops within hours after initiation of damage. Lung injury was measured by differenr parameters, such as leukocyte sequesrra- 
[ion, histologic damage, or increase in vascular permeability. 
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Fig. 2. Effects of rhTNF on endothelium of the small intestine. 
Ten yg of rhTNF were injected intravenously, the animals sacrificed 2 h later and the vascula- 
ture of the small intestine examined by electron microscopy. Panel a is normal histology with an 
intact endothelial cell. In b, the endothelial cell layer has retracted leaving the basement membrane 
exposed (arrow). Further damage is observed in panel c, with marked disruption of the endothelium 
and blebbing of the endothelial cell membrane (arrows). Reprinted with permission, Laboratory In- 
vestigation. 
testines when “pure” TNF was injected (1989). 
However, if there was contaminating endotoxin, then 
more widespread changes were observed. Attempts 
to define the mechanism of the bowel necrosis were 
made by Sun and Hsueh (1989). In their work, the 
necrosis induced by either LPS, recombinant TNF 
(0.5 mg/kg) or a combination of both agents could 
be blocked by a platelet-activating factor receptor 
antagonist. 
The physiologic effects of TNF were closely exa- 
mined by the infusion of 5.7 x lo4 units/kg/h for 
6 h in dogs (van Lanschot, Mealy, and Wilmore, 
1990). There was a decrease in intestinal blood flow 
despite fluid resuscitation. Upon completion of the 
study, 6 of 7 dogs had infarcts in the small bowel. 
Additional studies on the physiologic effects of 
rhTNF demonstrated that intravenous injection of 
0.25 mg/kg induced del’ayed gastric emptying and in- 
creased emptying of the caecum (Patton et al., 1987). 
Further work by this group showed that injection of 
16.5 mg/kg would induce necrosis and inflammation 
of the mucosa of the small bowel. The stomach and 
large intestine were less severely affected. The authors 
mention that human and muose TNF caused similar 
pathology. 
We have also closely examined the effect of 
recombinant human TNF in rodents and have shown 
that the intestines are the most severely injured or- 
gans (Remick et al., 1987). Intravenous injection of 
10 ug/mouse (0.45 mg/kg) induced watery diarrhoea 
within.2 h. There was evidence of increased vascu- 
lar permeability in the small bowel at 1 pg/mouse. 
No other organs showed evidence of vascular perme- 
ability at this dose, including the lungs. Ultrastruc- 
tural examination of the small bowel showed necrosis 
of the tips of the villi. There was severe damage to 
the endothelial cells. This consisted of swelling of the 
endothelial cells of the small bowel with exposed 
basement membranes (fig. 2). Since there was also 
evidence of shock (increased haematocrit), we postu- 
lated that much of the intestinal mucosal injury may 
have been due to poor perfusion. In this setting of 
decreased blood flow, the damage to the endothelium 
would be particularly significant ‘since it would ex- 
acerbate the decreased availability of oxygen and 
nutrients to the intestine. 
The weight of experimental evidence favours a 
role for TNF in lung injury. The data using anti-TNF 
antibodies to inhibit experimental animal models is 
compelling. The role of TNF in intestinal injury is 
less clear, and further work will be needed to clarify 
the issue. In particular, antibody inhibition studies 
are needed. 
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TNF-a has been shown to be involved in the 
pathogenesis of many inflammatory diseases includ- 
ing cerebral malaria (Grau ef al., 1987), BCG-induced 
granuloma formation (Kindler er al., 1989) and silica- 
induced pulmonary fibrosis (Piguet et al., 1990). Its 
pathogenetic role in autoimmune disease, however, 
is less clear (Jacob, 1992 ; Vassalli, 1992). In partic- 
ular, studies on a potential involvement of TNF in 
the pathogenesis of insulin-dependent diabetes mel- 
litus (DDM) produced controversial results so far, 
pointing to either a harmful or to a beneficial role 
of this cytokine in the destruction of /3 cells : system- 
ic administration of TNF-u to diabetes-prone NOD 
mice or BB rats delayed or even prevented the onset 
of IDDM (Satoh et a/., 1989, 1990; Jacob et a/., 
1990). A decrease in the extent of insulitis was ob- 
served when TNF-u was administered together with 
interferon-y (Campbell et al., 1991). The observation 
that, upon stimulation of peritoneal macrophages 
from NOD mice, there was only low production of 
TNF-a led to the assumption that reduced capacity 
to produce TNF-a predisposes to IDDM. However, 
the fact that in diabetes-prone BB rats, elevated TNF 
production by activated macrophages is observed be- 
fore insulitis occurs (Rothe et al., 1990), does not sup- 
port such a concept. The disease-preventing effects 
of systemic administration of TNF-u in NOD mice 
or diabetes-prone BB rats (Satoh et al., 1989, 1990; 
